(MedPage Today) -- Studies this week in Annals of the Rheumatic Diseases highlighted the potential role for MRI in predicting progression in early rheumatoid arthritis (RA), negative results with fostamatinib, and the use of statins among patients taking rituximab (Rituxan). via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment